Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution  Jesmond Dalli, Romain A. Colas, Hildur.

Slides:



Advertisements
Similar presentations
Volume 42, Issue 2, Pages (February 2015)
Advertisements

Volume 34, Issue 3, Pages (March 2011)
Volume 20, Issue 13, Pages (September 2017)
Volume 43, Issue 1, Pages (July 2015)
Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease  Louise China, Alexander Maini, Simon S. Skene,
Volume 42, Issue 1, Pages (January 2015)
Volume 40, Issue 1, Pages (January 2014)
Volume 29, Issue 3, Pages (September 2008)
Volume 42, Issue 3, Pages (March 2015)
Ravi Malaviya, Christopher Navara, Fatih M Uckun  Immunity 
Volume 34, Issue 3, Pages (March 2011)
Volume 30, Issue 4, Pages (April 2009)
Suk-Jo Kang, Hong-Erh Liang, Boris Reizis, Richard M. Locksley 
Volume 39, Issue 2, Pages (August 2013)
by Jesmond Dalli, and Charles N. Serhan
Volume 45, Issue 1, Pages (July 2016)
Catecholamine Stress Alters Neutrophil Trafficking and Impairs Wound Healing by β2- Adrenergic Receptor–Mediated Upregulation of IL-6  Min-Ho Kim, Farzam.
Volume 20, Issue 2, Pages (February 2013)
Volume 42, Issue 2, Pages (February 2015)
Volume 22, Issue 1, Pages (July 2015)
Volume 15, Issue 6, Pages (June 2014)
Volume 36, Issue 1, Pages (January 2012)
Inflammatory Monocytes Activate Memory CD8+ T and Innate NK Lymphocytes Independent of Cognate Antigen during Microbial Pathogen Invasion  Saïdi M'Homa.
Volume 165, Issue 3, Pages (April 2016)
Volume 29, Issue 2, Pages (August 2008)
Volume 17, Issue 5, Pages (May 2015)
Volume 29, Issue 2, Pages (August 2008)
Volume 46, Issue 6, Pages e4 (June 2017)
Volume 20, Issue 1, Pages (July 2016)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Mycobacterium tuberculosis Inhibits Neutrophil Apoptosis, Leading to Delayed Activation of Naive CD4 T cells  Robert Blomgran, Ludovic Desvignes, Volker.
Volume 44, Issue 6, Pages (June 2016)
Volume 33, Issue 4, Pages (October 2010)
Volume 33, Issue 1, Pages (July 2010)
Volume 37, Issue 5, Pages (November 2012)
Volume 36, Issue 5, Pages (May 2012)
Volume 45, Issue 1, Pages (July 2016)
Volume 39, Issue 5, Pages (November 2013)
Volume 41, Issue 5, Pages (November 2014)
Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and Retention  Nu.
Volume 28, Issue 5, Pages (May 2008)
Volume 40, Issue 1, Pages (January 2014)
Volume 33, Issue 4, Pages (October 2010)
Volume 45, Issue 1, Pages (July 2016)
Volume 48, Issue 4, Pages e4 (April 2018)
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
Oral Tolerance Can Be Established via Gap Junction Transfer of Fed Antigens from CX3CR1+ Macrophages to CD103+ Dendritic Cells  Elisa Mazzini, Lucia Massimiliano,
Volume 30, Issue 2, Pages (February 2009)
Volume 14, Issue 2, Pages (August 2013)
Volume 33, Issue 3, Pages (September 2010)
Volume 38, Issue 3, Pages (March 2013)
Volume 20, Issue 10, Pages (September 2017)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 37, Issue 5, Pages (November 2012)
Volume 31, Issue 5, Pages (November 2009)
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
Volume 31, Issue 5, Pages (November 2009)
Volume 33, Issue 5, Pages (November 2010)
Volume 37, Issue 6, Pages (December 2012)
Volume 21, Issue 10, Pages (October 2014)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 34, Issue 5, Pages (May 2011)
Volume 28, Issue 5, Pages (May 2008)
Volume 38, Issue 2, Pages (February 2013)
Volume 36, Issue 5, Pages (May 2012)
Volume 32, Issue 1, Pages (January 2010)
Volume 41, Issue 4, Pages (October 2014)
Volume 33, Issue 5, Pages (November 2010)
Volume 19, Issue 6, Pages (May 2017)
Volume 31, Issue 5, Pages (November 2009)
Presentation transcript:

Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution  Jesmond Dalli, Romain A. Colas, Hildur Arnardottir, Charles N. Serhan  Immunity  Volume 46, Issue 1, Pages 92-105 (January 2017) DOI: 10.1016/j.immuni.2016.12.009 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 Vagotomy Diminishes PCTR1 Concentrations and Elevates Eicosanoids in Peritoneum Mice were subjected to right unilateral vagotomy or sham surgery, at the indicated intervals the peritoneal cavity was lavaged, and lipid mediators were profiled using LC-MS-MS based LM metabololipidomics (see Experimental Procedures for details). (A and B) Representative multiple reaction chromatograms for identified lipid mediators (A) and MS-MS spectrum employed in the identification of PCTR1 (B). (C) Lipid mediator profiles were then interrogated using partial least square discriminant analysis (PLS-DA). Top: 2D score plot; bottom: 2D loading plot. (D) Peritoneal acetylcholine levels. Results for (A)–(C) are representative of n = 5–6 mice per group from two distinct experiments. Results for (D) are mean ± SEM. n = 4–5 mice per group ∗∗p < 0.01 versus sham mice. m/z = mass to charge ratio. Immunity 2017 46, 92-105DOI: (10.1016/j.immuni.2016.12.009) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Resident Peritoneal ILC3 Numbers Are Reduced and Peritoneal Macrophage Phenotype Is Altered in Vagotomized Mice Mice were subjected to unilateral vagotomy or sham surgery, and peritoneal cells were collected at the indicated intervals. (A and B) ILC3 (A) and macrophage (B) numbers were determined using light microscopy and flow cytometry. (C) Peritoneal macrophage phenotypic marker expression was determined using flow cytometry and results interrogated using PLS-DA. Top: 2D score plot; bottom: 2D loading plot. (D) Peritoneal macrophages were isolated and lipid mediators determined using lipid mediator profiling. Results were then interrogated using PLS-DA. Top: 2D score plot; bottom: 2D loading plot. Results for (A) and (B) are mean ± SEM. 4–5 mice per group from two distinct experiments. Results for (C) and (D) are representative of 3–4 mice per group. Related to Figures S2 and S3 and Tables S1 and S2. Immunity 2017 46, 92-105DOI: (10.1016/j.immuni.2016.12.009) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 3 Vagotomy Delayed Resolution of Infections Mice were subjected to unilateral vagotomy or sham surgery; after 7 days E. coli (1 × 106 CFU/mouse) was administered via i.p. injection. Inflammatory exudates were collected at the indicated intervals. (A) Cell counts determined using light microscopy and flow cytometry and resolution indices calculated. (B) Exudate leukocyte phagocytosis of E. coli (CD11b+ E. coli+ cells) was determined by flow cytometry in 12 hr exudates. (C) 12 hr exudates were cultured on agar and bacterial loads were determined as colony-forming units (CFUs). Results are mean ± SEM. n = 4 mice per group from two distinct experiments. Related to Figure S3. Immunity 2017 46, 92-105DOI: (10.1016/j.immuni.2016.12.009) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 4 PCTR1 Restores Resolution Responses in Vagotomized Mice during Bacterial Infections For a Figure360 author presentation of Figure 4, see the figure online at http://dx.doi.org/10.1016/j.immuni.2016.12.009#mmc3. (A–C) Mice were subjected to unilateral vagotomy or sham surgery, and after 7 days vagotomized mice were administered vehicle (saline containing 0.01% EtOH) or PCTR1 (75 ng/mouse) via i.p. injection. (A and B) After 16 hr, peritoneal lavages were collected and macrophage phenotype was determined using flow cytometry (A) and peritoneal LM profiles were determined using LM metabololipidomics (B). (C) Peritoneal cells were collected, plated in 96-well plates (5 × 104 cells/well; DPBS; 2 hr; 37°C), then incubated with fluorescently labeled E. coli (2.5 × 106 CFU/well; 37°C, PBS+/+ [pH 7.45], 40 min) and phagocytosis was assessed using a fluorescence microscopy. Results for (C) are mean ± SEM. Results are representative of n = 5–6 mice per group from two distinct experiments. (D–G) Mice were administered E. coli (1 × 106 CFU/mouse, i.p.). Exudates were collected at the indicated intervals and neutrophil count determined using flow cytometry and light microscopy (D). 12 hr exudate leukocyte E. coli phagocytosis was determined as CD11b+ E. coli+ cells (E) and 12 hr exudate bacterial loads (F) and 24 hr exudate macrophage efferocytosis (G) determined as F4/80+ Ly6G+ cells. Related to Tables S3 and S4. Figure360: an author presentation of Figure 4 Immunity 2017 46, 92-105DOI: (10.1016/j.immuni.2016.12.009) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 5 ILC3s Regulate Peritoneal Macrophage Phenotype, PCTR1 Production, and Resolution of Infectious Inflammation Mice were subjected to right unilateral vagotomy or sham. Vagotomized mice were then administered vehicle (Vagotomy; PBS) or Carbachol (Vagotomy+Carbachol; 0.1 mg/kg/day for 7 days). (A–C) Peritoneal lavages were collected and expression of macrophage phenotypic markers (A), CD335+ ILC3s (B), and PCTR1 levels (C) were determined. Results for (A) are representative of n = 3 mice per group. Results for (B) and (C) are mean ± SEM of n = 3 mice per group. ∗p < 0.05. (D and E) Rag1−/− mice were administered an anti-CD90.2 (250 μg/mouse) or isotype control (250 μg/mouse) antibody. (D) Peritoneal lavages were collected and lipid mediator profiles determined using LC-MS-MS-based LM metabololipidomics and PLS-DA. Left: 2D score plot; right: 2D loading plot. (E) Peritoneal macrophages were collected and phenotypic marker expression determined using flow cytometry. Left: 2D score plot; right: 2D loading plot. Results are representative of n = 4 mice per group from two distinct experiments. (F–H) Rag1−/− mice were administered an anti-CD90.2 (250 μg/mouse) or isotype control (250 μg/mouse) antibody. After 3 days they were given E. coli (1 × 105 CFU/mouse) via i.p. injection, and exudates were collected at the indicated intervals. (F) Cell counts were determined using light microscopy and flow cytometry and resolution indices calculated. (G) Exudate leukocyte phagocytosis of E. coli (CD11b+ E. coli+ cells) was determined by flow cytometry in 12 hr exudates. (H) 12 hr exudates were cultured on agar and bacterial loads were determined as colony-forming units (CFUs). Results are mean ± SEM. n = 4 mice per group from two distinct experiments. Related to Table S6. Immunity 2017 46, 92-105DOI: (10.1016/j.immuni.2016.12.009) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 6 Acetylcholine Upregulates SPM Biosynthetic Pathways in Human and Mouse ILC3s that Restore Peritoneal Host Responses to Infections in Vagotomized Mice (A) Expression of mouse 12/15-LOX in mouse CD335+ ILC3s. Results are representative of n = 3 mice. (B) Mouse ILC3s were isolated using FACS sorting (see Experimental Procedures) then incubated with DHA (300 ng/mL) then with ACh (1 nM, 37°C, PBS+/+ [pH 7.45], 60 min). Incubations were then quenched and 17-HDHA levels assessed using LM metabololipidomics. Results are mean ± SEM. n = 3 mice per group. (C) Peritoneal macrophages (Mϕ; 1 × 106 cells/well) from vagotomized mice were incubated with mCD335+ ILC3s (7.5 × 102 cells/well, 6 hr, 37°C, PBS+/+, 2% FBS). Incubations were quenched and PCTR1 levels determined using lipid mediator profiling. Results are mean ± SEM; n = 3 mice per group. ∗p < 0.05 versus Mϕ; #p < 0.05 is Mϕ plus ILC3. (D) Omenta were isolated from naive mice and stained for choline acetyltransferase (red), CD3 (green), F4/80 (cyan), and RoRγt (white) and staining was imaged using confocal microscopy (see Experimental Procedures for details). Magnification ×40. Results are representative of n = 4 mice. (E) Mice were subjected to unilateral vagotomy surgery; after 7 days they were administered vehicle, CD335+ ILC3s (5 × 102 cells), DHA (1 μM) plus ACh (1 nM), or CD335+ ILC3s (5 × 102 cells), DHA (1 μM), ACh (1 nM) plus lipoxygenase inhibitor (10 μM; L.I.; see Experimental Procedures for details) 3 hr prior to E. coli (1 × 106 CFU/mouse). At the indicated intervals leukocytes were collected and neutrophil counts determined by light microscopy and flow cytometry. (F) Exudate bacterial loads 12 hr after E. coli inoculation. Results are mean ± SEM. n = 4 mice per group from two distinct experiments. (G) Human ILC3 expression of 15-lipoxygenase type I (15-LOX) was determined by flow cytometry. Results are representative of n = 4 donors. (H) Mice were subjected to unilateral vagotomy surgery, after 7 days they were administered vehicle, ILC3s (1 × 103 cells), DHA (1 μM) plus ACh (1 nM), or ILC3s (1 × 103 cells), DHA (1 μM), ACh (1 nM) plus lipoxygenase inhibitor (10 μM; L.I.; see Experimental Procedures for details) 3 hr prior to E. coli (1 × 106 CFU/mouse; see Experimental Procedures for details). At the indicated intervals leukocytes were collected and neutrophil counts determined by light microscopy and flow cytometry. Results are mean ± SEM. n = 6 mice per group from two distinct experiments. Immunity 2017 46, 92-105DOI: (10.1016/j.immuni.2016.12.009) Copyright © 2017 Elsevier Inc. Terms and Conditions